Scarica l'app Stockscreener
5.34
3.09%
-0.17
Dopo l'orario di chiusura:
5.40
0.06
+1.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNKD Giù?
Forum
Previsione
Frazionamento azionario
Mannkind Corp Borsa (MNKD) Ultime notizie
MannKind Corporation stock prediction for this week2025 Market Overview & AI Enhanced Execution Alerts - Newser
MannKind Corporation recovery potential after sell offTrade Exit Summary & Community Consensus Trade Signals - Newser
MannKind stock price target raised to $11 by H.C. Wainwright on Tyvaso success - Investing.com
MannKind (MNKD) Expands United Therapeutics Deal Can New Platform Revenues Transform Its Long-Term Story? - simplywall.st
What to expect from MannKind Corporation in the next 30 daysBond Market & Weekly Chart Analysis and Trade Guides - Newser
MannKind Corporation (NASDAQ:MNKD) Looks Just Right With A 53% Price Jump - simplywall.st
Can MannKind Corporation recover in the next quarterWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Mannkind Corporation shares rise 1.22% premarket after United Therapeutics' drug Tyvaso shows significant lung function improvement. - AInvest
Published on: 2025-09-03 02:55:27 - Newser
Can trapped investors hope for a rebound in MannKind CorporationJuly 2025 Selloffs & Reliable Trade Execution Plans - Newser
Forecasting MannKind Corporation price range with options dataIPO Watch & Weekly Watchlist for Hot Stocks - Newser
Combining machine learning predictions for MannKind CorporationJuly 2025 Recap & Safe Capital Investment Plans - Newser
Can MannKind Corporation ride the EV waveShare Buyback & Target Return Focused Picks - خودرو بانک
Trend analysis for MannKind Corporation this weekMarket Activity Report & Real-Time Volume Spike Alerts - Newser
Does MannKind Corporation show high probability of reboundJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Historical volatility pattern of MannKind Corporation visualized2025 Market Overview & Smart Allocation Stock Reports - Newser
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results - Stocktwits
Is MannKind Corporation stock a buy or sellQuarterly Performance Summary & Low Drawdown Momentum Ideas - خودرو بانک
Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7 - MSN
Applying chart zones and confluence areas to MannKind CorporationPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser
What MACD and RSI say about MannKind CorporationMarket Sentiment Review & Verified Momentum Watchlists - Newser
Mannkind (MNKD) Surges 25% on Strategic Acquisition and Financing Hints – What’s Next? - AInvest
Full technical analysis of MannKind Corporation stockJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser
United Therapeutics Shares Surge on Strong Lung-Drug Trial Results - citybiz
MannKind Corporation Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - kangso.co.kr
What momentum shifts mean for MannKind CorporationDay Trade & Fast Momentum Entry Tips - Newser
United’s Tyvaso surprise in IPF potentially opens $4B market - BioWorld MedTech
Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - inkl
MannKind Stock Surges Anew: Buy or Hold? - StocksToTrade
Mannkind Soars 38.13% on Strategic Acquisition of scPharmaceuticals - AInvest
MNKD Shares Plunge: Should Investors Worry? - timothysykes.com
How to integrate MannKind Corporation into portfolio analysis toolsJuly 2025 EndofMonth & Real-Time Sentiment Analysis - Newser
Has MannKind Corporation formed a bullish divergence2025 Trade Ideas & Free Accurate Trade Setup Notifications - Newser
Is MannKind Corporation currently under institutional pressureGap Up & Safe Entry Trade Reports - خودرو بانک
H.C. Wainwright Reiterates a Buy Rating on MannKind Corporation (MNKD) - MSN
Applying big data sentiment scoring on MannKind CorporationJuly 2025 PostEarnings & Safe Entry Zone Tips - Newser
How MannKind Corporation stock performs during market volatilityTrade Exit Summary & Risk Controlled Stock Alerts - Newser
How to recover losses in MannKind Corporation stockWall Street Watch & Verified Technical Signals - Newser
MannKind Corporation Could See a Relief Rally From Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Candlestick signals on MannKind Corporation stock todayBond Market & Safe Capital Investment Plans - Newser
Regression analysis insights on MannKind Corporation performanceMarket Volume Report & Weekly High Momentum Picks - Newser
Is now a turning point for MannKind CorporationJuly 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Analyzing recovery setups for MannKind Corporation investors2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
Published on: 2025-08-31 07:53:49 - Newser
What makes MannKind Corporation stock price move sharplyQuarterly Earnings Report & Low Risk High Reward Trade Ideas - Newser
When is the best time to exit MannKind CorporationMarket Sentiment Summary & Safe Entry Zone Tips - Newser
MannKind's Strategic Acquisition of scPharmaceuticals: A Catalyst for Diversified Growth and Long-Term Value Creation - AInvest
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):